Companies Launched

ACTSI resources offer funding for start-up research projects, better access to analytical tools, and education and training to clinical and translational investigators. ACTSI provides the infrastructure and programmatic foundation to rapidly identify and invest in promising technologies and enhance collaborative opportunities among translational investigators and industry partners. A goal of ACTSI is to catalyze development, validation, and commercialization of translational technologies. Through this mechanism, four companies used ACTSI support to launch and begin reaching patients.
Read More

Contact

Pamela Bhatti, PhD, MSCR

Upcoming Events

View All Events

Discovery News

Discovery

ACTSI Part of the SMART IRB Movement to Accelerate Multisite Clinical Studies

ACTSI partners, Emory University, Morehouse School of Medicine, Georgia Institute of Technology, and the University of Georgia, are practicing team science and are proud to be part of the National Institutes of Health (NIH) National Center for...

Discovery

Infographic: Biostatistics, Epidemiology, & Research Design (BERD)

ACTSI-supported BERD provides comprehensive biostatistical and epidemiological support, clinical protocol reviews, and educational resources for early career researchers.